TMJ 'dysfunction' - Health implications

Within this forum, you will discover valuable insights on how a 'dysfunctional' jaw, dental arch anomalies, and various body asymmetries can contribute to illness from a unique perspective. This is your go-to resource for finding effective solutions and achieving lasting relief.
It is currently Tue, 19 Mar 2024, 4:37 am

All times are UTC [ DST ]




Post new topic Reply to topic  [ 1 post ] 
Author Message
PostPosted: Sun, 28 Apr 2013, 11:07 am 
Offline
Site Admin

Joined: Fri, 28 Sep 2012, 9:08 pm
Posts: 216
CCSVI April

Posted:
Epub: Radak et al. Percutaneous angioplasty of internal jugular and azygous veins in patients with chronic cerebrospinal venous insufficiency and multiple sclerosis: early and mid-term results. Phlebology. 2013 Apr.

Purpose: To assess the safety of endovascular treatment of chronic cerebrospinal venous insufficiency (CCSVI) in patients with multiple sclerosis(MS).

Materials and Methods:
A total of 72 patients with CCSVI and MS (44 with relapsing remitting - RR, 4 with primary progressive, 20 with secondary progressive and 4 with benign MS) underwent percutaneous angioplasty. Outcome measures were colour Doppler ultrasonography parameters, gradient pressure at the vein abnormality level, postoperative complications, re-stenosis, disease severity scored by means of Expanded Disability Status Scale (EDSS) and patients' assumption of disease status. Controls were done after one month on 72 patients, six months on 69 patients and one year on 61 patients, respectively (the average follow-up was 11 months).

Results: There were no post-operative complications. Colour Doppler ultrasonography showed significant improvement in cross-sectional area parameters (P < 0.05) and significant decrease in confluence velocity values (P < 0.05). Postoperative gradient pressure decreased, in internal jugular vein (IJV) significantly (P < 0.05). Re-stenosis appeared in 5.3% of patients. EDSS score was significantly improved (P < 0.01) and about half of patients reported significant or mild improvement in disease status and none of them worsening of symptoms.

Conclusion: Endovascular treatment of the IJV and azygous veins in patients with CCSVI and MS is a safe procedure with no post-procedural complications followed by significant improvement of IJV flow haemodynamic parameters and decrease in the EDSS score. Whether CCSVI percutaneous treatment might affect clinical improvement in patients suffering from MS is yet to be seen after completion of major multicentre clinical trials, still it seems like that this procedure is not negligible.


Share on FacebookShare on TwitterShare on TuentiShare on SonicoShare on FriendFeedShare on OrkutShare on DiggShare on MySpaceShare on DeliciousShare on TechnoratiShare on TumblrShare on Google+
Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC [ DST ]


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot post attachments in this forum

Search for:
Jump to:  
Rules of the BoardThe teamDelete all board cookies
cron
Disclaimer: Please read our Disclaimer of warranties and limitation of liability
Also see information on Intellectual Property Rights
Before posting, please read our Board Rules
Powered by phpBB® Forum Software © phpBB Group